Antibody and interleukin-12 treatment in murine models of encephalitogenic flavivirus (St. Louis encephalitis, tick-borne encephalitis) and alphavirus (Venezuelan equine encephalitis) infection.
J Interferon Cytokine Res
; 23(1): 47-50, 2003 Jan.
Article
em En
| MEDLINE
| ID: mdl-12639298
ABSTRACT
Early and sustained treatment with interleukin-12 (IL-12) ameliorated disease in a mouse model of infection with the encephalitogenic flavivirus, St. Louis encephalitis virus (SLEV, Japanese encephalitis serogroup). However, this effect was not reproduced in murine infections with either the flavivirus tick-bore encephalitis virus (TBEV) or the alphavirus Venezuelan equine encephalitis virus (VEEV). IL-12 exacerbated TBEV disease when used in conjunction with monoclonal antibody (mAb), suggesting an enhancement of immunopathology, and was without clinical effects in VEEV infection. These data confirm the need to fully understand the pathogenesis of viral infection before cytokine intervention may be employed as a broad-spectrum antiviral therapy.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Interleucina-12
/
Encefalite de St. Louis
/
Encefalite Transmitida por Carrapatos
/
Encefalomielite Equina Venezuelana
/
Anticorpos Monoclonais
Tipo de estudo:
Prognostic_studies
Limite:
Animals
País como assunto:
America do sul
/
Venezuela
Idioma:
En
Ano de publicação:
2003
Tipo de documento:
Article